Position in CADL
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$1,503,964
+$1,147,901 QoQ
Shares Held
146,016
+100.9% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 138 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Derivatives in CADL
reported options exposure · as of Jun 30, 2026CallValue
$454,230
CallShares
44,100
PutValue
$636,540
PutShares
61,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. CADL ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in CADL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,503,964 | 146,016 | Shares | Defined | 2026-09-02 | |
| 2026-06-30 | $454,230 | 44,100 | Call | Defined | 2026-09-02 | |
| 2026-06-30 | $636,540 | 61,800 | Put | Defined | 2026-09-02 | |
| 2026-03-31 | $356,063 | 72,666 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $265,090 | 54,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $621,500 | 110,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $120,910 | 21,400 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,278,911 | 226,356 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $631,890 | 123,900 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,286,684 | 252,291 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $169,830 | 33,300 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $190,256 | 37,600 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,548,360 | 306,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $270,635 | 47,900 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $54,443 | 9,636 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $1,528,325 | 270,500 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $2,448,628 | 282,100 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $2,527,173 | 291,149 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $993,860 | 114,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $589,050 | 85,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $699 | 101 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $177,408 | 25,600 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $373,240 | 60,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $88,660 | 14,300 | Put | Defined | 2024-08-14 | |
| 2023-12-31 | $24,772 | 16,852 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,579 | 32,152 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $63,684 | 47,174 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $52,912 | 16,851 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||